AZZONI EMANUELE

Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD, 143(14), 1399-1413 [10.1182/blood.2023021349]. Detail

Zaghi, M., Banfi, F., Massimino, L., Volpin, M., Bellini, E., Brusco, S., et al. (2023). Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition. NATURE COMMUNICATIONS, 14(1) [10.1038/s41467-023-39043-x]. Detail

Cossu, G., Tonlorenzi, R., Brunelli, S., Sampaolesi, M., Messina, G., Azzoni, E., et al. (2023). Mesoangioblasts at 20: From the embryonic aorta to the patient bed. FRONTIERS IN GENETICS, 13 [10.3389/fgene.2022.1056114]. Detail

Barone, C., Orsenigo, R., Cazzola, A., D'Errico, E., Patelli, A., Quattrini, G., et al. (2023). Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation. CANCERS, 15(14) [10.3390/cancers15143624]. Detail

Barone, C., Orsenigo, R., Meneveri, R., Brunelli, S., Azzoni, E. (2022). One Size Does Not Fit All: Heterogeneity in Developmental Hematopoiesis. CELLS, 11(6) [10.3390/cells11061061]. Detail